Skip to main content

Recent Stories

Advertorial

SAN FRANCISCO, March 20, 2026 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) announced today that data from the ongoing Phase 2b studies of rezpegaldesleukin in atopic dermatitis and alopecia areata have been accepted for two oral presentations at the 2026 American Academy of Dermatology…

Advertorial

SAN FRANCISCO, March 20, 2026 /PRNewswire/ -- NeutronX Corporation ("NeutronX"), a technology integrator focused on artificial intelligence and energy infrastructure, today announced that Scott Mauvais, former Senior Director of AI and Global Partnerships for Microsoft Philanthropies and for…